Neuron-specific enolase and S-100B are associated with neurologic outcome after pediatric cardiac arrest

Pediatric Critical Care Medicine

Volumn 10, Issue 4, 2009, Pages

  Topjian, Alexis A ^a   Lin, Richard ^a   Morris, Marilyn C ^c   Ichord, Rebecca ^b   Drott, Henry ^b   Bayer, Carey R ^d   Helfaer, Mark A ^a   Nadkarni, Vinay ^a  

^a Department of Anesthesiology and Critical Care Medicine ^*  (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Children's Hospital of New York Presbyterian   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Biological markers; Children; Heart arrest; Nerve tissue protein S 100; Neuron specific enolase; Prognosis

Indexed keywords

INSULIN; NEURON SPECIFIC ENOLASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN S100B; STEROID;

ARTICLE; ASTHMATIC STATE; BLOOD SAMPLING; BRAIN FUNCTION; BRAIN INJURY; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ARREST; HUMAN; HYPOTENSION; MALE; MENTAL PERFORMANCE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCHOOL CHILD; SURVIVAL RATE; SURVIVOR; TERTIARY HEALTH CARE;

EID: 70349297599     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e318198bdb5     Document Type: Article

References (67)

1. Slonim AD, Patel KM, Ruttimann UE, et al.: Cardiopulmonary resuscitation in pediatric intensive care units. Crit Care Med 1997; 25:1951-1955
2. Nadkarni VM, Larkin GL, Peberdy MA, et al.: First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA 2006; 295:50-57
3. Schindler MB, Bohn D, Cox PN, et al.: Outcome of out-of-hospital cardiac or respiratory arrest in children. N Engl J Med 1996; 335:1473-1479
4. Zingler VC, Krumm B, Bertsch T, et al.: Early prediction of neurological outcome after cardiopulmonary resuscitation: A multimodal approach combining neurobiochemical and electrophysiological investigations may provide high prognostic certainty in patients after cardiac arrest. Eur Neurol 2003; 49: 79-84
5. Tiainen M, Roine RO, Pettila V, et al.: Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke 2003; 34:2881-2886
6. Schoerkhuber W, Kittler H, Sterz F, et al.: Time course of serum neuron-specific eno-lase. A predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 1999; 30:1598-1603
7. Rosen H, Sunnerhagen KS, Herlitz J, et al.: Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001; 49: 183-191
8. Rosen H, Rosengren L, Herlitz J, et al.: Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 1998; 29:473-477
9. Pfeifer R, Borner A, Krack A, et al.: Outcome after cardiac arrest: Predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation 2005; 65: 49-55
10. Mussack T, Biberthaler P, Kanz KG, et al.: Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med 2002; 30:2669-2674
11. Meynaar IA, Straaten HM, van der Wetering J, et al.: Serum neuron-specific enolase predicts outcome in post-anoxic coma: A prospective cohort study. Intensive Care Med 2003; 29:189-195
12. Martens P, Raabe A, Johnsson P: Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29:2363-2366
13. Martens P: Serum neuron-specific enolase as a prognostic marker for irreversible brain damage in comatose cardiac arrest survivors. Acad Emerg Med 1996; 3:126-131
14. Geppert A, Zorn G, Delle-Karth G, et al.: Plas-minogen activator inhibitor type 1 and outcome after successful cardiopulmonary resuscitation. Crit Care Med 2001; 29: 1670-1677
15. Bottiger BW, Mobes S, Glatzer R, et al.: As-troglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001; 103:2694-2698
16. Hachimi-Idrissi S, van der Auwera M, Schi-ettecatte J, et al.: S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest. Resuscitation 2002; 53:251-257
17. Fogel W, Krieger D, Veith M, et al.: Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med 1997; 25:1133-1138
18. Reisinger J, Hollinger K, Lang W, et al.: Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase. Eur Heart J 2007; 28:52-58
19. Zandbergen EG, Hijdra A, Koelman JH, et al.: Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology 2006; 66:62-68
20. Schmechel D, Marangos PJ, Zis AP, et al.: Brain endolases as specific markers of neu-ronal and glial cells. Science 1978; 199: 313-315
21. D'Alessandro M, Mariani P, Lomanto D, et al.: Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendo-crine tumors. Tumour Biol 1992; 13: 352-357
22. Zeltzer PM, Marangos PJ, Evans AE, et al.: Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 1986; 57: 1230-1234
23. Zeltzer PM, Marangos PJ, Parma AM, et al.: Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group. Lancet 1983; 2:361-363
24. Berger RP, Dulani T, Adelson PD, et al.: Iden-tification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: A possible screening tool. Pediatrics 2006; 117:325-332
25. Nagdyman N, Grimmer I, Scholz T, et al.: Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr Res 2003; 54: 270-275
26. Tekgul H, Yalaz M, Kutukculer N, et al.: Value of biochemical markers for outcome in term infants with asphyxia. Pediatr Neurol 2004; 31:326-332
27. Berger RP, Adelson PD, Richichi R, et al.: Serum biomarkers after traumatic and hy-poxemic brain injuries: Insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev Neurosci 2006; 28:327-335
28. Hu J, Ferreira A, Van Eldik LJ: S100beta induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 1997; 69:2294-2301
29. Selinfreund RH, Barger SW, Pledger WJ, et al.: Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc Natl Acad Sci USA 1991; 88:3554-3558
30. Spinella PC, Dominguez T, Drott HR, et al.: S-100beta protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 2003; 31:939-945
31. Spinella PC, Donoghue A, Rajendra A, et al.: Cerebrospinal fluid levels of S-100beta in children and its elevation in pediatric meningitis. Pediatr Crit Care Med 2004; 5:53-57
32. Pinsky DJ, Liao H, Lawson CA, et al.: Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasmin-ogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 1998; 102:919-928
33. Gando S, Nakanishi Y, Tedo I: Cytokines and plasminogen activator inhibitor-1 in post-trauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction syndrome. Crit Care Med 1995; 23: 1835-1842
34. Gando S, Kameue T, Nanzaki S, et al.: Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 1997; 77:278-282
35. Jacobs I, Nadkarni V, Bahr J, et al.: Cardiac arrest and cardiopulmonary resuscitation outcome reports: Update and simplification of the Utstein templates for resuscitation registries: A statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, In-terAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation 2004; 110:3385-3397
36. Fiser DH, Long N, Roberson PK, et al.: Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1- and 6-month follow-up assessments. Crit Care Med 2000; 28:2616-2620
37. Finer NN, Robertson CM, Richards RT, et al.: Hypoxic-ischemic encephalopathy in term neonates: Perinatal factors and outcome. J Pediatr 1981; 98:112-117
38. Sarnat HB, Sarnat MS: Neonatal encephalop-athy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976; 33:696-705
39. Akcan-Arikan A, Zappitelli M, Loftis LL, et al.: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71:1028-1035
40. Nsiri B, Gritli N, Bayoudh F, et al.: Abnormalities of coagulation and fibrinolysis in ho-mozygous sickle cell disease. Hematol Cell Ther 1996; 38:279-284
41. Berger RP, Adelson PD, Pierce MC, et al.: Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after in-flicted and noninflicted traumatic brain injury in children. J Neurosurg 2005; 103(Suppl 1):61-68
42. Berger RP, Pierce MC, Wisniewski SR, et al.: Neuron-specific enolase and S100B in cere-brospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002; 109:E31
43. Berger RP, Pierce MC, Wisniewski SR, et al.: Serum S100B concentrations are increased after closed head injury in children: A preliminary study. J Neurotrauma 2002; 19: 1405-1409
44. Shore PM, Berger RP, Varma S, et al.: Bi-omarkers and diagnosis; cerebrospinal fluid biomarkers versus Glasgow Coma Scale and Glasgow Outcome Scale in pediatric traumatic brain injury: The role of young age and inflicted injury. J Neurotrauma 2007; 24: 75-86
45. Meaney PA, Nadkarni VM, Cook EF, et al.: Higher survival rates among younger patients after pediatric intensive care unit cardiac arrests. Pediatrics 2006; 118: 2424-2433
46. Samson RA, Nadkarni VM, Meaney PA, et al.: Outcomes of in-hospital ventricular fibrilla-tion in children. N Engl J Med 2006; 354: 2328-2339
47. Zaritsky A, Nadkarni V, Hazinski MF, et al.: Recommended guidelines for uniform reporting of pediatric advanced life support: The pediatric Utstein style. A statement for healthcare professionals from a task force of the American Academy of Pediatrics, the American Heart Association, and the European Resuscitation Council. Pediatrics 1995; 96(4 Pt 1):765-779
48. Lindberg L, Olsson AK, Anderson K, et al.: Serum S-100 protein levels after pediatric cardiac operations: A possible new marker for postperfusion cerebral injury. J Thorac Cardiovasc Surg 1998; 116:281-285
49. DeGiorgio CM, Heck CN, Rabinowicz AL, et al.: Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 1999; 52:746-749
50. Palmio J, Peltola J, Vuorinen P, et al.: Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. J Neurol Sci 2001; 183:27-31
51. Raabe A, Grolms C, Sorge O, et al.: Serum S-100B protein in severe head injury. Neurosurgery 1999; 45:477-483
52. Suzuki Y, Toribe Y, Goto M, et al.: Serum and CSF neuron-specific enolase in patients with West syndrome. Neurology 1999; 53: 1761-1764
53. Missler U, Wiesmann M, Friedrich C, et al.: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute isch-emic stroke. Stroke 1997; 28:1956-1960
54. LIA-mat Sangrtec 100 Immunoluminetric assay for the quantification of protein S-100B package insert
55. Snyder-Ramos SA, Gruhlke T, Bauer H, et al.: Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthe-sia 2004; 59:344-349
56. Routsi C, Stamataki E, Nanas S, et al.: Increased levels of serum S100B protein in critically ill patients without brain injury. Shock 2006; 26:20-24
57. Bernard SA, Gray TW, Buist MD, et al.: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563
58. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-556
59. Balasa VV, Gruppo RA, Glueck CJ, et al.: The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost 1999; 81:739-744
60. Estelles A, Dalmau J, Falco C, et al.: Plasma PAI-1 levels in obese children-Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Thromb Haemost 2001; 86: 647-652
61. Hajnal BL, Sahebkar-Moghaddam F, Barn-well AJ, et al.: Early prediction of neurologic outcome after perinatal depression. Pediatr Neurol 1999; 21:788-793
62. Shevell MI, Majnemer A, Miller SP: Neonatal neurologic prognostication: The asphyxiated term newborn. Pediatr Neurol 1999; 21: 776-784
63. Levy DE, Caronna JJ, Singer BH, et al.: Predicting outcome from hypoxic-ischemic coma. JAMA 1985; 253:1420-1426
64. Mullie A, Verstringe P, Buylaert W, et al.: Predictive value of Glasgow Coma Score for awakening after out-of-hospital cardiac arrest. Cerebral Resuscitation Study Group of the Belgian Society for Intensive Care. Lan-cet 1988; 1:137-140
65. Lieh-Lai MW, Theodorou AA, Sarnaik AP, et al.: Limitations of the Glasgow Coma Scale in predicting outcome in children with traumatic brain injury. J Pediatr 1992; 120(2 Pt 1):195-199
66. Piazza O, Storti MP, Cotena S, et al.: S100B is not a reliable prognostic index in paediatric TBI. Pediatr Neurosurg 2007; 43:258-264
67. Prohl J, Rother J, Kluge S, et al.: Prediction of short-term and long-term outcomes after cardiac arrest: A prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations. Crit Care Med 2007; 35: 1230-1237